UNITE4TB—an international public-private partnership aiming to accelerate the development of innovative tuberculosis treatments—has announced the successful completion of participant recruitment for
Please use the image only in connection with the press release.
Treatment with Linezolid, an antibiotic that is used against multi-resistant tuberculosis bacteria, leads to adverse drug reactions in around a quarter of patients, including certain nerve disorders
"Infektiopod", a podcast in German language that has been providing information on human infectious diseases since 2019, is now being funded by the German Center for Infection Research (DZIF). The
INCATE, the INCubator for Antimicrobial Therapies in Europe co-founded by the German Center for Infection Research, has been honoured with the 2024 Lighthouse Award for outstanding Transfer of
DZIF professors Marc Hübner and Achim Hörauf are part of the international team that has now been awarded the Horizon Prize 2024 by the Royal Society of Chemistry.
Around 150 experts from various stakeholder groups—including a number of scientists from the network of the German Center for Infection Research (DZIF)—have developed a roadmap for improving
The German Center for Infection Research (DZIF) is again offering the DZIF Prize for Translational Infection Research. Scientists can apply to the DZIF Academy until 6 October 2024. A prize of 5,000
The microbiome, i.e. the microorganisms that colonise our gut and help with digestion, weighs around one and a half kilograms. It consists primarily of bacteria and also has a protective effect
Members of Parliament (MPs) from the CDU, FDP, SPD and Die Linke parties have joined forces in a parliamentary group to focus more on combating antimicrobial resistance in the future.
HYpharm's innovative preventive agent HY-133 has reached the first clinical trial phase. HY-133 is specifically effective against the bacterial pathogenStaphylococcus aureus including multi-resistant
